EQS-Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)

Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering

Related Keywords

Geneva ,Genè ,Switzerland ,Secheron ,Switzerland General ,United States ,Swiss ,Paolo Galfetti ,Michael Miller ,Jack Weinstein ,Advita Lifescience Gmb ,Relief Therapeutics Holding Sa Key ,Linkedin ,Pharma Research ,Swiss Exchange ,Rx Communications Group ,Physiomimic Technology ,Trademark Office ,Relief Therapeutics Holding ,News Service ,Neurorx Inc ,Therapeutic Wholly Owned Subsidiary ,Receives Notice ,Application Covering ,Patent Application ,Strengthens Proprietary Position ,Chief Executive Officer ,Vasoactive Intestinal Peptide ,License Agreement ,Acer Therapeutics ,Urea Cycle Disorders ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Financial Officer ,Adhoc ,Relief ,Herapeutics ,Molding ,Holly ,Wned ,Ubsidiary ,Applied ,Dharma ,Research ,Eceives ,Notice ,Allowance ,Patent ,Application ,Covering ,Bolike ,